Literature DB >> 32138965

Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation.

Giovanni Peretto1, Simone Sala2, Stefania Rizzo3, Anna Palmisano4, Antonio Esposito4, Francesco De Cobelli4, Corrado Campochiaro5, Giacomo De Luca5, Luca Foppoli6, Lorenzo Dagna5, Gaetano Thiene3, Cristina Basso3, Paolo Della Bella2.   

Abstract

BACKGROUND: Ventricular arrhythmias (VAs) have never been systematically investigated in patients with myocarditis at different stages.
OBJECTIVES: The purpose of this study was to compare baseline and follow-up characteristics of VAs in patients with active myocarditis (AM) versus previous myocarditis (PM).
METHODS: A total of 185 consecutive patients (69% males, age 44 ± 15 years, left ventricular ejection fraction 49 ± 14%) with myocarditis and VA at index hospitalization, including ventricular fibrillation, ventricular tachycardia (VT), nonsustained ventricular tachycardia (NSVT), and Lown's grade ≥2 premature ventricular complexes, were enrolled. AM and PM groups were defined based on endomyocardial biopsy and cardiac magnetic resonance findings. A subset of patients (n = 46, 25%) also underwent electroanatomic mapping and VA transcatheter ablation.
RESULTS: At presentation, AM patients (n = 123, 66%) more commonly had ventricular fibrillation (8 cases vs. 0 cases; p = 0.053), and both irregular (61% vs. 11%; p < 0.001) and polymorphic VA (NSVT and VT: 19% vs. 2%; p = 0.002; premature ventricular complexes: 63% vs. 16%; p < 0.001). Only in PM patients with NSVT or VT, the dominant morphology (right-bundle branch block with superior axis) was 100% predictive of abnormal LV inferoposterior substrate at both cardiac magnetic resonance and electroanatomic mapping. At 27 ± 7 months prospective follow-up, 55 patients (30%) experienced malignant VA (AM vs. PM, p = 0.385). Although a prevalence of polymorphic and irregular VA was confirmed in AM patients with persistent inflammation in follow-up (58%), a predominance of monomorphic and regular VA was found in AM patients after myocarditis healing (42%), as well as in PM patients (all p < 0.001).
CONCLUSIONS: In myocarditis patients, polymorphic and irregular VA are more common during the active inflammatory phase, whereas monomorphic and regular VA are associated with healed myocarditis.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiac magnetic resonance; electroanatomic mapping; endomyocardial biopsy; myocarditis; ventricular arrhythmias

Mesh:

Year:  2020        PMID: 32138965     DOI: 10.1016/j.jacc.2020.01.036

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  35 in total

Review 1.  Anti-Arrhythmic Effects of Sodium-Glucose Co-Transporter 2 Inhibitors.

Authors:  Yuling Jing; Ruixue Yang; Wen Chen; Qiang Ye
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

Review 2.  Electroimmunology and cardiac arrhythmia.

Authors:  Jana Grune; Masahiro Yamazoe; Matthias Nahrendorf
Journal:  Nat Rev Cardiol       Date:  2021-03-02       Impact factor: 32.419

3.  Unintentional Consequences.

Authors:  Edward M Wojtys
Journal:  Sports Health       Date:  2021 Jan/Feb       Impact factor: 3.843

Review 4.  Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?

Authors:  Maria Vincenza Polito; Angelo Silverio; Michele Bellino; Giuseppe Iuliano; Marco Di Maio; Carmine Alfano; Patrizia Iannece; Nicolino Esposito; Gennaro Galasso
Journal:  Cardiol Ther       Date:  2021-06-30

Review 5.  Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management.

Authors:  Bhurint Siripanthong; Saman Nazarian; Daniele Muser; Rajat Deo; Pasquale Santangeli; Mohammed Y Khanji; Leslie T Cooper; C Anwar A Chahal
Journal:  Heart Rhythm       Date:  2020-05-05       Impact factor: 6.343

Review 6.  Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle.

Authors:  Aldostefano Porcari; Antonio De Luca; Chrysanthos Grigoratos; Federico Biondi; Giorgio Faganello; Giancarlo Vitrella; Gaetano Nucifora; Giovanni Donato Aquaro; Marco Merlo; Gianfranco Sinagra
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

7.  Implications of SARS-CoV-2-Associated Myocarditis in the Medical Evaluation of Athletes.

Authors:  Neha P Raukar; Leslie T Cooper
Journal:  Sports Health       Date:  2020-11-17       Impact factor: 3.843

8.  Sudden cardiac death risk in contact sports increased by myocarditis: a case series.

Authors:  Grégoire Massoullié; Baptiste Boyer; Vincent Sapin; Frédéric Jean; Marius Andronache; Michel Peoc'h; Guillaume Clerfond; Romain Eschalier
Journal:  Eur Heart J Case Rep       Date:  2021-03-01

9.  The Role of the Automated Implantable Cardioverter Defibrillator (AICD) for Secondary Prevention in the COVID-19 Era.

Authors:  Andrew V Doodnauth; Jordan I Zhou; Krunal H Patel; Fadi Yacoub; Julian Dunkley
Journal:  Cureus       Date:  2021-06-20

Review 10.  Myocardial infarction or acute coronary syndrome with non-obstructive coronary arteries and sudden cardiac death: a missing connection.

Authors:  Nikolaos Kosmas; Antonis S Manolis; Nikolaos Dagres; Efstathios K Iliodromitis
Journal:  Europace       Date:  2020-09-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.